Intellia Therapeutics, Inc. (NTLA)
12.55
-0.29
(-2.26%)
USD |
NASDAQ |
Aug 24, 16:00
12.55
0.00 (0.00%)
After-Hours: 20:00
Intellia Therapeutics Gross Profit Margin (Quarterly) : 72.58% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 72.58% |
| March 31, 2026 | 85.37% |
| December 31, 2025 | 73.87% |
| September 30, 2025 | 64.19% |
| June 30, 2025 | 82.45% |
| March 31, 2025 | 84.98% |
| December 31, 2024 | 80.07% |
| September 30, 2024 | 71.38% |
| June 30, 2024 | 62.64% |
| March 31, 2024 | 91.32% |
| December 31, 2023 | |
| September 30, 2023 | 80.90% |
| June 30, 2023 | 84.04% |
| March 31, 2023 | 83.74% |
| December 31, 2022 | 85.04% |
| September 30, 2022 | 85.30% |
| June 30, 2022 | 86.91% |
| March 31, 2022 | 84.41% |
| December 31, 2021 | 85.37% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.00K% |
| Twist Bioscience Corp. | 52.76% |
| Tenaya Therapeutics, Inc. | -52.97% |
| Moderna, Inc. | -7.59% |
| Arrowhead Pharmaceuticals, Inc. | 91.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.41% |
| Return on Assets | -46.70% |
| Return on Invested Capital | -50.87% |
| Profit Margin (Quarterly) | -1.39K% |
| Operating Margin (Quarterly) | -1.47K% |
| Return on Net Operating Assets | -260.4% |